The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of RC88 in patients with ovarian cancer, non-squamous-non-small-cell lung-carcinoma and cervical cancer: Results from a first-in-human phase 1/2 study.
 
Yutao Liu
Research Funding - RemeGen
 
Guiling Li
Research Funding - PI of RemeGen-supported study
 
Runxiang Yang
Research Funding - PI of RemeGen-supported study
 
Yu Huang
Research Funding - PI of RemeGen-supported study
 
Suxia Luo
Consulting or Advisory Role - KYM Biosciences
 
Qi Dang
Research Funding - PI of RemeGen-supported study
 
Qingshui Li
Research Funding - PI of RemeGen-supported study
 
Dingzhi Huang
No Relationships to Disclose
 
Yi Huang
Research Funding - PI of RemeGen-supported study
 
Dihong Tang
Research Funding - PI of RemeGen-supported study
 
Xiubao Ren
No Relationships to Disclose
 
Youzhong Zhang
Research Funding - PI of RemeGen-supported study
 
Yuguang Zhao
Research Funding - PI of RemeGen-supported study
 
Baorui Liu
Research Funding - PI of RemeGen-supported study
 
Jin Zhou
No Relationships to Disclose
 
Yanjie Wang
Employment - Remegen Co., Ltd.
 
Heping Liu
Employment - Remegen Co., Ltd.
 
Beisong Liu
Employment - Remegen Co., Ltd.
Research Funding - Remegen Co., Ltd.
 
Jianmin Fang
Employment - RemeGen Co., Ltd.; Remegen Co., Ltd. (I)
Leadership - RemeGen Co., Ltd.; Remegen Co., Ltd.
Stock and Other Ownership Interests - RemeGen Co., Ltd.; Remegen Co., Ltd. (I)
Consulting or Advisory Role - RemeGen Co., Ltd., Beijing, China
 
Yuankai Shi
No Relationships to Disclose